Contineum Therapeutics Inc-A

Small-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$12.21

+0.10 (+0.83%)

As of Mar 22, 10:20 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 85%

Hold 2 15%

Sell 0 0%

Price Target

Analyst Price Target +217.9% upside

Low Target $27.95

Average Target $38.82

High Target $46.43

Current Price $12.21

Current
$12.21

Target
$38.82

$27.95 $38.82 avg $46.43

Scenario Analysis

Bear Case

$27.95

128.9%

Low target

Base Case

$38.82

+217.9%

Avg target

Bull Case

$46.43

+280.3%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$16.01

-23.7% from high

52-Week Low

$3.35

+264.5% from low

Target vs 52W High

$38.82

+142.5% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+45.2%
JNJ Johnson & Johnson	Buy	32	59%	$299.55	+24.8%
MRK Merck & Co. Inc.	Buy	36	67%	$159.27	+33.4%
PFE Pfizer Inc.	Hold	35	40%	$33.90	+24.3%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+196.1%
ZTS Zoetis Inc	Buy	25	64%	$209.87	+79.8%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-22.9%
VTRS Viatris Inc	Buy	18	67%	$122.82	+809.8%